PL438052A1 - Phenothiazine derivatives and their application - Google Patents

Phenothiazine derivatives and their application

Info

Publication number
PL438052A1
PL438052A1 PL438052A PL43805221A PL438052A1 PL 438052 A1 PL438052 A1 PL 438052A1 PL 438052 A PL438052 A PL 438052A PL 43805221 A PL43805221 A PL 43805221A PL 438052 A1 PL438052 A1 PL 438052A1
Authority
PL
Poland
Prior art keywords
phenothiazine derivatives
application
branched
subject
formula
Prior art date
Application number
PL438052A
Other languages
Polish (pl)
Other versions
PL243640B1 (en
Inventor
Aneta Słodek
Sylwia Zimosz
Katarzyna Malarz
Robert Musioł
Grażyna Szafraniec-Gorol
Original Assignee
Uniwersytet Śląski W Katowicach
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Uniwersytet Śląski W Katowicach filed Critical Uniwersytet Śląski W Katowicach
Priority to PL438052A priority Critical patent/PL243640B1/en
Publication of PL438052A1 publication Critical patent/PL438052A1/en
Publication of PL243640B1 publication Critical patent/PL243640B1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/10—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D279/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one sulfur atom as the only ring hetero atoms
    • C07D279/10—1,4-Thiazines; Hydrogenated 1,4-thiazines
    • C07D279/14—1,4-Thiazines; Hydrogenated 1,4-thiazines condensed with carbocyclic rings or ring systems
    • C07D279/18—[b, e]-condensed with two six-membered rings
    • C07D279/22—[b, e]-condensed with two six-membered rings with carbon atoms directly attached to the ring nitrogen atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09K—MATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K11/00—Luminescent, e.g. electroluminescent, chemiluminescent materials
    • C09K11/06—Luminescent, e.g. electroluminescent, chemiluminescent materials containing organic luminescent materials
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/531—Production of immunochemical test materials
    • G01N33/532—Production of labelled immunochemicals
    • G01N33/533—Production of labelled immunochemicals with fluorescent label

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Materials Engineering (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Biotechnology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)

Abstract

Przedmiotem wynalazku są pochodne fenotiazyny, które mają postać chemiczną przedstawioną wzorem 1, gdzie R oznacza grupę alkilową zawierającą od 1 do 20 atomów węgla, również rozgałęzioną oraz ich zastosowanie jako fluorescencyjnych sond molekularnych do barwienia struktur biologicznych.The subject of the invention are phenothiazine derivatives, which have a chemical form represented by the formula 1, where R is an alkyl group containing from 1 to 20 carbon atoms, also branched, and their use as fluorescent molecular probes for staining biological structures.

PL438052A 2021-06-02 2021-06-02 Phenothiazine derivatives and their application PL243640B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
PL438052A PL243640B1 (en) 2021-06-02 2021-06-02 Phenothiazine derivatives and their application

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PL438052A PL243640B1 (en) 2021-06-02 2021-06-02 Phenothiazine derivatives and their application

Publications (2)

Publication Number Publication Date
PL438052A1 true PL438052A1 (en) 2022-12-05
PL243640B1 PL243640B1 (en) 2023-09-25

Family

ID=84426760

Family Applications (1)

Application Number Title Priority Date Filing Date
PL438052A PL243640B1 (en) 2021-06-02 2021-06-02 Phenothiazine derivatives and their application

Country Status (1)

Country Link
PL (1) PL243640B1 (en)

Also Published As

Publication number Publication date
PL243640B1 (en) 2023-09-25

Similar Documents

Publication Publication Date Title
CY1120477T1 (en) Receiver-actuator actuator actuated by sub-multipliers
SA521421235B1 (en) Compositions With Improved Urease-Inhibiting Effect Comprising (Thio)Phosphoric Acid Triamide And Further Compounds Such As Amines And Colorants
AR052866A1 (en) SUBSTITUTED MONOCICLIC PHENYL-METANONES
CY1108313T1 (en) PRODUCTS OF KINOLIN AND USE FOR 5-HT6 PROJECTS
CY1113799T1 (en) DELMOPINOL PREPARATION
EA201000017A1 (en) PRELIMINARY COMPOSITION OF SULFUR CEMENT AND METHOD OF PREPARATION OF PRELIMINARY COMPOSITION OF SULFUR CEMENT
EA201171328A1 (en) Derivative Isoquinoline Derivative
CY1113519T1 (en) VENZAZEPIN PRODUCTS USEFUL AS VASOPRESINE COMPONENTS
AR074021A1 (en) FUSIONED HETEROCICLICAL COMPOUNDS AS IONIC CHANNEL MODULATORS
EA202092921A1 (en) POLYCYCLIC DERIVATIVE OF CARBAMOYLPIRIDONE
CY1113873T1 (en) HYDROXYBENZAMIDE DERIVATIVES AS HSP90 SUPPORTING AGENTS
UY31232A1 (en) COMPOUNDS DERIVED FROM DIBENZOTIFENILAMINO-CROMEN-4-ACTIVE WAVES REPLACED AND ITS ISOMERS AND APPLICATIONS
CY1118170T1 (en) NEW PHOSPHICAL ACIDS AND THEIR SULFUR PRODUCERS AND METHODS FOR THEIR PREPARATION
EA200600487A1 (en) COMPOUNDS OF INDANILPIPERAZIN, METHOD OF THEIR RECEIVING AND CONTAINING THEIR PHARMACEUTICAL COMPOSITIONS
HK1155739A1 (en) A benzimidazole derivative as a calcium channel blocker
RU2014124531A (en) (1R, 4R) 7-OXO-2-AZABICYCLO [2.2.2] OCT-5-EH AND ITS DERIVATIVES
BR0312608A (en) Liquid Adjuvants
ATE428693T1 (en) PROSTAGLAND INSYNTHESIS
PL438052A1 (en) Phenothiazine derivatives and their application
EA200970497A1 (en) PYRROLA DERIVATIVES, THEIR PRODUCTION AND THEIR APPLICATION IN THERAPY
EA201590501A1 (en) COMPOUND, NUCLEIC ACID, SUBSTANCE, MARK BEARING, AND DETECTION METHOD
CY1111653T1 (en) PHARMACEUTICAL COMPOSITION OF 2,3-DYHYDRO-6-NITROMIMIDAZO [2,1-B] OXAZOLI PRODUCTS
EA200300997A1 (en) LINEAR OLEG-LACTATE COMPLEX ETHER
EA201000982A1 (en) 19-NOR-STEROID DERIVATIVES WITH 15α, 16α-METHYLENE GROUP AND SATURATED 17,17-SPYROLACTON RING, THEIR APPLICATION AND MEDICINES CONTAINING THIS DERIVATIVES
BR112018075803A2 (en) improved process for carbamate preparation